Vancomycin Hydrochloride molecular structure

Vancomycin Hydrochloride

Also known as: Vancocin, Vancoled, Lyphocin

CAS Number: 1404-93-9

Glycopeptide antibiotic — first-line MRSA treatment

Pharmacopeia Standards

USPBPEP

Mechanism of Action

Tricyclic glycopeptide antibiotic produced by Amycolatopsis orientalis. Inhibits bacterial cell wall synthesis by binding the D-Ala-D-Ala terminus of peptidoglycan precursors (lipid II), blocking transpeptidase and transglycosylase enzymes. Bactericidal against gram-positive cocci. Cannot penetrate gram-negative outer membrane. Resistance (VRE) mediated by D-Ala-D-Lac or D-Ala-D-Ser substitution (vanA/vanB operons).

Technical Specifications

Generic / INN NameVancomycin Hydrochloride
CAS Registry Number1404-93-9
Molecular FormulaC66H75Cl2N9O24·HCl
Molecular Weight1485.71 g/mol
Typical Purity900–1050 μg/mg (potency, anhydrous basis)
Storage ConditionsStore below 25°C; reconstituted solution: refrigerate (2–8°C), use within 96h
Shelf Life24 months from date of manufacture
CategoryGlycopeptides

Specifications are indicative and intended for sourcing reference only. Always confirm against the supplier's Certificate of Analysis and the applicable pharmacopeial monograph before issuing a purchase specification.

Typical Applications

MRSA infections (bacteremia, endocarditis, pneumonia, osteomyelitis — primary treatment), coagulase-negative Staphylococcal infections (prosthetic valve endocarditis, CRBSI), Enterococcal endocarditis (with gentamicin), C. difficile colitis (oral vancomycin — first-line for severe/complicated cases), surgical prophylaxis in beta-lactam-allergic patients, CNS infections (MRSA meningitis).

Manufacturers (1+)

View all →

India

WHO-GMPUS-FDAEU-GMP
Contact (Premium)